Home › Research › Mild cognitive impairment
Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of Aging
Pankratz VS, Roberts RO, Mielke MM, Knopman DS, Jack CR, Geda YE, Rocca WA, Petersen RC.. Neurology, 2015-03-18
Topic: Risk, prevention and care in population studies
Plain-language summary
Objective We sought to develop risk scores for the progression from cognitively normal (CN) to mild cognitive impairment (MCI). Methods We recruited into a longitudinal cohort study a randomly selected, population-based sample of Olmsted County, MN, residents, aged 70 to 89 years on October 1, 2004. At baseline and subsequent visits, participants were evaluated for demographic, clinical, and neuropsychological measures, and were classified as CN, MCI, or dementia. Using baseline demographic and clinical variables in proportional hazards models, we derived scores that predicted the risk of progressing from CN to MCI. We evaluated the ability of these risk scores to classify participants for MCI risk. Results Of 1,449 CN participants, 401 (27.7%) developed MCI. A basic model had a C statistic of 0.60 (0.58 for women, 0.62 for men); an augmented model resulted in a C statistic of 0.70 (0.69 for women, 0.71 for men). Both men and women in the highest vs lowest sex-specific quartiles of the augmented model's risk scores had an approximately 7-fold higher risk of developing MCI. Adding APOE ε4 carrier status improved the model (p = 0.002). Conclusions We have developed MCI risk scores using variables easily assessable in the clinical setting and that may be useful in routine patient care. Because of variability among populations, validation in independent samples is required. These models may be useful in identifying patients who might benefit from more expensive or invasive diagnostic testing, and can inform clinical trial design. Inclusion of biomarkers or other risk factors may further enhance the models.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study. In 1,449 cognitively normal people aged 70 to 89, 401 (27.7%) developed mild cognitive impairment, and a risk score using easily assessable clinical variables classified risk, with those in the highest quartile having about a 7-fold higher risk than the lowest. Reported effect size: 27.7%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Pankratz, V. S., Roberts, R. O., Mielke, M. M., Knopman, D. S., Jack, C. R., Geda, Y. E., et al. (2015). Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of Aging. Neurology. https://doi.org/10.1212/wnl.0000000000001437
Vancouver
Pankratz VS, Roberts RO, Mielke MM, Knopman DS, Jack CR, Geda YE, et al. Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of Aging. Neurology. 2015. doi:10.1212/wnl.0000000000001437. PMID: 25788555.
BibTeX
@article{pankratz2015-25788555,
author = {Pankratz, V. S. and Roberts, R. O. and Mielke, M. M. and Knopman, D. S. and Jack, C. R. and Geda, Y. E. and Rocca, W. A. and Petersen, R. C.},
title = {{Predicting the risk of mild cognitive impairment in the Mayo Clinic Study of Aging}},
journal = {Neurology},
year = {2015},
doi = {10.1212/wnl.0000000000001437},
pmid = {25788555},
url = {https://doi.org/10.1212/wnl.0000000000001437}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Results Of 1,449 CN participants, 401 (27.7%) developed MCI.
- Both men and women in the highest vs lowest sex-specific quartiles of the augmented model's risk scores had an approximately 7-fold higher risk of developing MCI.
Why it matters
In 1,449 cognitively normal people aged 70 to 89, 401 (27.7%) developed mild cognitive impairment, and a risk score using easily assessable clinical variables classified risk, with those in the highest quartile having about a 7-fold higher risk than the lowest. Adding APOE ε4 carrier status improved the model, but the authors note validation in independent samples is required, and no treatment or prevention is tested.
Study details
- Study designcohort study
- Effect size27.7%
- Evidence strengthModerate
How this study scored 62/100
Published in a leading specialty journal, and it is a cohort study following people over time. Scored zero for sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Neurology) |
| Journal's citation record | 4 / 4 | Neurology: journal h-index 525 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2015 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 5 / 7 | Cited 138 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 10.6 citations a year over 13 year(s) since 2015 |
| Impact for its field and year | 4 / 6 | Cited 9.2× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 8 other studies in this library |
| Still being cited | 2 / 4 | Cited 22 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Ronald Carl Petersen: h-index 209 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | Mayo Clinic: institution h-index 1,606 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 25788555) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 62 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 14.
Later studies that cite this one
8 studies in the alzhub library list this one in their references.
Related studies in Mild cognitive impairment from nearby years
Also tagged “mini-mental”
840 studies in the library carry the topic tag “mini-mental”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 840 tagged studies.